Combining chemotherapy and immunotherapy for advanced anal cancer: are we ready?

Lancet Oncol. 2024 Apr;25(4):416-417. doi: 10.1016/S1470-2045(24)00131-1.

Authors

Erika Martinelli¹, Davide Ciardiello²

Affiliations

¹ Medical Oncology Unit, Department of Precision Medicine, University of Campania Luigi Vanvitelli, Naples, Italy. Electronic address: erika.martinelli@unicampania.it.
² Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumours, European Institute of Oncology, IRCCS, Milan, Italy.

PMID: 38547889
DOI: 10.1016/S1470-2045(24)00131-1

No abstract available

MeSH terms

Anus Neoplasms* / drug therapy
Combined Modality Therapy
Humans
Immunotherapy / adverse effects